Stocks · News reference
Analysts have reduced the average 12-month price target for Medical Properties Trust, Inc. to $3.25, citing updated market forecasts.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Multiple law firms have announced ongoing securities fraud investigations into Medical Properties Trust, Inc. following the company's October 29, 2026, disclosure regarding tenant rent payment issues.
BNP Paribas has downgraded Medical Properties Trust from Outperform to Neutral, setting a price target of $2.25.
RBC Capital Markets downgraded Medical Properties Trust to Underperform from Sector Perform and lowered its price target to $2 from $4.50.
Medical Properties Trust, Inc. announced its financial and operating results for the third quarter ended September 30, 2026, reporting net income of $0.34 per share and Normalized Funds from Operations (NFFO) of $0.11 per share.
Filed: 2026-10-29 AccNo: 0001193125-26-437067 Size: 7 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits